MedTrace Logo

The Effect of CoQ10 Administration on Hemodialysis Patients

NCT00307996 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2006-03-28

No results posted yet for this study

Summary

The purpose of this study is to examine whether CoQ10 administration is effective as an antioxidant in hemodialysis patients.

Conditions

  • Chronic Renal Failure
  • Hemodialysis

Interventions

DRUG

Coenzyme Q10 (drug)

Sponsors & Collaborators

  • University of Shizuoka

    lead OTHER

Principal Investigators

  • Hiromichi Kumagai, MD · University of Shizuoka

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Completion
2004-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00307996 on ClinicalTrials.gov